ASX Share rice
Fri 14 Aug 2020 - 08:08:pm (Sydney)

AFP Share Price

AFT PHARMACEUTICALS LIMITEDAFPPharmaceuticals, Biotechnology & Life Sciences

AFP Company Information


AFT Pharmaceuticals Limited




Drug Manufacturers—Specialty & Generic


129 Hurstmere Road Auckland New Zealand 0622


64 9 488 0232

Full Time Employees:


Founder, CEO, MD & Exec. Director:

Dr. Hartley Atkinson

Chief of Staff & Exec. Director:

Ms. Marree Atkinson

CFO & Company Sec.:

Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ

Group Marketing Mang.:

Mr. Murray Keith

Head of Drug Devel.:

Ms. Ioana Stanescu

Company Overview:

AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.

AFP Share Price Information

Shares Issued:


Market Capitalisation:


Profit Margin:


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


QuarterlyEarnings Growth(YOY):


AFP CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:


Dividends Paid:


Capital Expenditures:


AFP Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Income Tax Expense:


Total Revenue:


Cost Of Revenue:


AFP Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Long-Term Debt:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


AFP Share Price History

AFP News

13 Jul, 2020
The big shareholder groups in AFT Pharmaceuticals Limited (NZSE:AFT) have power over the company. Institutions often...
24 May, 2020
AFT Pharmaceuticals Limited (NZSE:AFT) defied analyst predictions to release its full-year results, which were ahead...
08 May, 2020
By buying an index fund, you can roughly match the market return with ease. But many of us dare to dream of bigger...
08 Feb, 2020
Hartley Atkinson became the CEO of AFT Pharmaceuticals Limited (NZSE:AFT) in 1997. This report will, first, examine...
25 Nov, 2019
BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License and Supply Agreement (“the Agreement”) with AFT Pharmaceuticals (“AFT”, NSX: AFT, ASX: AFP) for a portfolio of new pain management products for the Canadian market. Health Canada has recently approved the first form of Combogesic® and BioSyent Pharma Inc. intends to launch the product in 2020. Under the Agreement, BioSyent Pharma Inc. also has rights to additional forms of Combogesic® - some of which have been approved in other countries and for which it intends to seek approval in Canada.
10 Nov, 2019
Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...